Vanguard realigns reporting; multiple entities to report ACMR holdings separately (ACMR)
Rhea-AI Filing Summary
ACM Research Inc — The Vanguard Group filed a Schedule 13G/A (Amendment No. 3) reporting 0 shares and 0% beneficial ownership of ACM Research Inc common stock as disclosed in the amendment.
The filing explains that on January 12, 2026 Vanguard completed an internal realignment and certain subsidiaries or business divisions will report beneficial ownership separately on a disaggregated basis in reliance on SEC Release No. 34-39538. The submission is signed by Vanguard's Head of Global Fund Administration on March 26, 2026.
Positive
- None.
Negative
- None.
Insights
Vanguard reports no beneficial stake after internal realignment.
Vanguard's amendment states 0 shares and 0% ownership in ACM Research Inc, attributing the change to an internal reorganization effective January 12, 2026. The filing relies on SEC Release No. 34-39538 to disaggregate reporting among subsidiaries.
Cash‑flow treatment is not included in the excerpt; subsequent filings from Vanguard or the subsidiaries may show separate schedules if they hold shares. Market impact depends entirely on whether any affiliated subsidiary reports a material ownership stake.
FAQ
What did the Schedule 13G/A filed for ACMR by Vanguard report?
Why does The Vanguard Group show zero ownership of ACM Research Inc (ACMR)?
Does this filing mean Vanguard sold ACMR shares?
When was the Schedule 13G/A amendment signed and filed?
Will other Vanguard entities report ownership of ACMR instead?